monoclonal antibody (Everest Medicines)

N/A

Report date: 2026/05/27 10:30:42

Base Information

Drug Namemonoclonal antibody (Everest Medicines)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNephrosis, LipoidGlomerulosclerosis, Focal SegmentalGlomerulonephritis, Membranous +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEverest Medicines Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines Ltd
Inactive CompaniesN/A
Active IndicationsNephrosis, LipoidGlomerulosclerosis, Focal SegmentalGlomerulonephritis, Membranous +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A